A 'rising fog' may cloud the immune system's ability to detect tumors and may be the key to tackling lung cancer that is developing years before diagnosis. The team at University College London (UCL) followed this signal using prototype blood tests and reversed it using drugs.
'Immune fog' may indicate lung cancer risk long before diagnosis
Researchers at University College London have identified a phenomenon termed 'immune fog' that may hinder the immune system's ability to detect lung cancer years before it manifests. They have developed prototype blood tests to track this signal and have found ways to reverse it using medication. This research could have implications for cancer detection and treatment in Iran, where healthcare advancements are critical.
👥 Key Players
📰 What Happened
Researchers at University College London have discovered a phenomenon called 'immune fog' that may prevent the immune system from detecting lung cancer early. They have developed blood tests to track this signal and identified drugs that can reverse it.
- The phenomenon 'immune fog' could indicate lung cancer years before diagnosis.
- Prototype blood tests and drug treatments are being developed to address this issue.
💡 Why It Matters
📚 Background
Lung cancer is one of the leading causes of cancer-related deaths worldwide, and early detection is critical for effective treatment. Advances in medical research can significantly impact public health outcomes.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%